Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort-Reference-Cited by-同舟云学术

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Published:2014-05 Issue:6 Volume:15 Page:640-647
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Gianni Luca,Eiermann Wolfgang,Semiglazov Vladimir,Lluch Ana,Tjulandin Sergei,Zambetti Milvia,Moliterni Angela,Vazquez Federico,Byakhov Mikhail J,Lichinitser Mikhail,Climent Miguel Angel,Ciruelos Eva,Ojeda Belen,Mansutti Mauro,Bozhok Alla,Magazzù Domenico,Heinzmann Dominik,Steinseifer Jutta,Valagussa Pinuccia,Baselga Jose

Publisher

Elsevier BV

Subject

Oncology

Reference18 articles.

1. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer;Piccart-Gebhart;N Engl J Med,2005

2. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

3. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

4. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer;Joensuu;N Engl J Med,2006

5. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer;Buzdar;J Clin Oncol,2005

Cited by 411 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Radiation Therapy Modalities on Loco-regional Control in Inflammatory Breast Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Advances from targeted therapy for non‐metastatic HER2‐positive inflammatory breast cancer;Journal of Surgical Oncology;2024-08-05

3. Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Recent Advances and Strategies;JCO Oncology Practice;2024-08

4. Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer;Annals of Surgical Oncology;2024-06-17

5. Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data;Cureus;2024-05-04